Mitoxantrone Recruiting Phase 2 Trials for Relapsed or Refractory Peripheral T-cell and NK/T-cell Lymphoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03776279A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma